The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.
IP portfolio to clinical-stage biopharmaceutical assetsXTL Biopharmaceuticals (XTL) Completes the Acquisition of Psyga Bio and ...
One of the most detailed maps to date of meningioma, the most common brain tumor in adults, reveals how the tumor’s ...
Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...
Pithy yet powerful, the Instagram bio can turn a casual scroller into an engaged follower—or send them straight to the back button. Let’s dive into the do’s and don’ts of crafting a bio that actually ...
Bio-Gene Technology (ASX: BGT) has received approval from the Organic Materials Review Institute in the US to list its Qcide natural insecticide as a Botanical Pesticide under the USDA National ...
Wyoming Valley West football will have a new coach next season and a new PIAA classification. The Spartans were among five District 2 programs — three from the Wyoming Valley Conference — which moved ...
The Georgia High School Association placed its 454 member schools into seven classifications on Monday in preparation for the 2026-27 school year. Fifty-six schools are slated to go up in class, while ...
Unlock the potential for faster, more comprehensive leukemia characterization with this webinar from Dana-Farber Cancer Institute expert Salvatore Benfatto. Acute leukemia (AL) is an aggressive form ...
Findings presented at LUPUS 2025 show virtual SLE Classification Program (PROACTIVE ™) classified SLE cases in just over one year versus traditional five-to-seven-year timeline OKLAHOMA CITY, May 27, ...
The Carnegie Foundation for the Advancement of Teaching and the American Council on Education debut a new classification system focused on student success. As widespread public skepticism about the ...